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The central dogma of molecular biology describes the flow of genetic informa-
tion from genes to functions of the cells and organisms. This comprises a two-step 
process: first, DNA, the permanent, heritable, genetic information repository, is 
transcribed by the RNA polymerase enzymes into RNA, a short-lasting information 
carrier; second, a subset of RNA, the messenger RNAs, mRNAs, are translated into 
protein. The transcriptome, then, is the complete set of all RNA molecules in a cell, 
a population of cells or in an organism.
Importantly, not all RNAs are translated into proteins, some serve a struc-
tural function, for example, rRNAs in the assembly of ribosomes, others are 
transporters, e.g., tRNAs, yet others serve regulatory functions, for example, the 
siRNAs, short interfering RNA, or lncRNAs, long non-coding RNAs; these are 
not translated into proteins [1]. However, these non-coding RNAs can and often 
do play roles in human diseases such as cancer, cardiovascular, and neurologi-
cal disorders. While transcriptomics is most commonly applied to the mRNAs, 
the coding transcripts, transcriptomics also provides important data regarding 
content of the cell noncoding RNAs, including rRNA, tRNA, lncRNA, siRNA, and 
others. Specific approaches address the analysis of splice variant of the same gene 
in different tissues.
1. Transcriptome analysis
Transcriptome Analysis is the study of the transcriptome, of the complete set of 
RNA transcripts that are produced by the genome, under specific circumstances or 
in a specific cell, using high-throughput methods. Transcription profiling, which 
follows changes in behavior of a cell in toto, not of a single gene or just a few genes, 
is used throughout diverse areas of biomedical research, including disease diagno-
sis, biomarker discovery, risk assessment of new drugs or environmental chemicals 
etc. Transcription profiling can be applied to loss- and gain-of-function mutants 
to identify the changes associated with the mutant phenotype. The transcriptomic 
techniques have been particularly useful in identifying the functions of genes. 
Transcriptomics also allows identification of pathways that respond to or ameliorate 
environmental stresses. RNA-Seq can also identify disease-associated gene fusions, 
single nucleotide polymorphisms and even allele-specific expression.
2. Uses of transcriptome analysis
Transcriptome Analysis is most commonly used to compare specific pairs of 
samples. The differences may be due to different external environmental condi-
tions, e.g., hormonal effects or toxins. More commonly, healthy and disease states 
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are compared. For example, in cancer, transcriptomics analyses address classifica-
tion, the mechanisms of pathogenesis and even outcome prediction. Transcriptome 
studies can classify cancer beyond anatomical location and histopathology. 
Outcome predictions can establish gene-based benchmarks to predict tumor prog-
nosis and therapy response. These approaches are already in use for personalized 
medicine, individualized cancer patient therapies.
Organisms and tissues at various stages of development can be molecularly char-
acterized. The transcriptomes of stem cells help to understand the processes of cel-
lular differentiation or embryonic development. Because of its very broad approach 
transcriptome analysis is a great source for identifying targets for treatment.
2.1 Methodologies
The early approach to study whole transcriptomes used microarrays, a set of 
defined sequences arranged on a solid substrate [2]. Microarrays almost exclusively 
represented mRNAs, that is, genes that are translated into proteins.
Nowadays the microarray approach is supplanted by high-throughput RNA 
sequencing, RNA-Seq, which detects all transcripts in a sample, including the 
regulatory siRNA and lncRNA transcripts [3]. In this methodology, the bulk RNA 
is extracted from the sample and copied into stable double-stranded copy DNA, 
ds-cDNA, which is then sequenced using various sequencing methods [4]. The 
sequences obtained are aligned to reference genome sequences, available in data 
banks, to identify which genes are transcribed. Quantitatively, the results provide 
the expression levels for the transcribed genes. Compared to microarrays, RNA-Seq 
can measure both the low-abundance and high-abundance RNAs over a five orders 
of magnitude range and, importantly, RNA-Seq requires much less starting mate-
rial (nanograms vs. micrograms and even as little as 50 pg) [5]. This made possible 
analyses of transcriptomes in a single cell, a great advance over bulk tissue RNA 
analyses [6]. RNA-seq can be used to identify alternative splicing, novel transcripts, 
and fusion genes (Table 1).
In principle, the assembly of RNA-Seq reads is not dependent on reference 
genomes and can be used for gene expression studies of poorly characterized 
species with limited genomic resources. It can also be used to identify novel protein 
coding regions in sequenced genomes. RNA-seq can be performed using many next-
generation sequencing platforms, however, each platform has its own requirements 
of sample preparation and the instrument design.
Table 1. 
Comparison of RNA-seq methodologies.
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2.2 Data analysis, repositories and presentation
Improved sequencing technologies necessitated improved data analysis methods 
to deal with the increased volume of data produced by each transcriptome experi-
ment. Importantly, the results are deposited into transcriptome databases, essential 
tools for transcriptome analysis. For example Gene Expression Omnibus, www.
ncbi.nml.nih.gov, contains millions of transcription profiling experiments. Such 
data have potential applications beyond the original aims of an experiment. Typical 
outputs include quantitative tables of the transcript levels. This requires specific 
analysis algorithms, often specific to the methodology used. There are software 
packages to bridge data from disparate methodologies, to identify groups of similar 
expressed genes, or differentially expressed functionally significant regulatory or 
metabolic pathways.
Figure 1. 
Graphic representations of transcriptome analysis data. (A) Heat map with clustering tree. (B) Venn diagrams 
of regulated genes.
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The results of transcriptomic analyses are graphically often presented as heat 
maps, a system of color-coding that represents different levels of expression of given 
genes in different samples (Figure 1A). Such presentations also frequently display 
a clustering of samples, this helps to identify samples with similar gene expression. 
Another common graphical presentation uses Venn diagrams, which count the 
transcripts which are equivalently regulated in multiple samples (Figure 1B).
Transcriptome analyses have become indispensable in basic research, transla-
tional, and clinical studies. In general, transcriptome analysis is a very powerful 
hypothesis-generating tool, more than a theory proving one.
3. Specific example: transcriptome analysis applied to human skin
Easily accessible, skin was among the first targets analyzed using ‘omics’ and 
dermatology embraced the approaches very early [7]. A classic example of coordi-
nated transcriptional regulation was observed in cultured fibroblasts after serum 
stimulation [2]. Serum addition causes not only rapid recommencement of the cell 
cycle but, characteristically a wound-healing response, a physiological role of fibro-
blasts in wound healing [8]. Transcriptional responses of epidermal keratinocytes 
to UV light, hormones, vitamins, infections, inflammatory and immunomodulating 
cytokines, toxins and allergens have been characterized, as were the changes associ-
ated with epidermal differentiation [9, 10].
The expression signatures that define the various cell types in human skin, were 
used to define 20 specific gene signatures, including those for keratinocytes, mela-
nocytes, endothelia, adipocytes, immune cells, hair follicles, sebaceous, sweat, 
and apocrine glands. This resource provided a resource named SkinSig, which was 
then used to analyze 18 skin conditions, providing in-context interpretation of, 
for example, influx in immune cells in inflammation or differentiation changes in 
disorders of cornification [11].
In the future we can anticipate a greatly expanded usage of transcriptome 
analysis. Translated to the bedside, it can provide better understanding and more 
specific diagnoses of diseases. This, of course, requires additional advances in the 
technology, both in the lab-bench components reducing the costs and guarantee-
ing reproducibility and accuracy, as well as in the computer-based components, 
algorithms that enable physicians to establish diagnosis quickly and reliably. In a 
generation, this approach will become routine.
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